Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hilger

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
A new oxygen-enriched solution enables human tumor tissue transport without cell devitalizationM Heim, R A Hilger, H Ruebben, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2003
Circadian rhythm in the regulation of the MAP kinase pathway--pitfall in the determination of surrogate parameters?R A Hilger, D Díaz-Carballo, S Bauer, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantationR A Hilger, J Baumgart, M E Scheulen, et al.
Applied and Environmental Microbiology|December 31, 2008
Molecular diversity of a North Carolina wastewater treatment plant as revealed by pyrosequencingNina Sanapareddy, Timothy J Hamp, Luis C Gonzalez, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
The growing number of hemophilia registries: Quantity vs. qualityC Keipert, J Hesse, B Haschberger, et al.
Seminars in Oncology|February 19, 2005
Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studiesDavid M Vail, Michael A Amantea, Gail T Colbern, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Comment on: Mannucci, P. M. Evolution of the European guidelines for the clinical development of factor VIII productsA Hilger, C Arras-Reiter, B Keller-Stanislawski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2014
Research in haemophilia B--approaching the request for high evidence levels in a rare diseaseK Berger, D Schopohl, A Hilger, et al.
Oncotarget|May 2, 2013
Cell death sensitization of leukemia cells by opioid receptor activationClaudia Friesen, Mareike Roscher, Inis Hormann, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumorsR A Hilger, A Harstrick, W Eberhardt, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
A new oxygen-enriched solution enables human tumor tissue transport without cell devitalizationM Heim, R A Hilger, H Ruebben, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2003
Circadian rhythm in the regulation of the MAP kinase pathway--pitfall in the determination of surrogate parameters?R A Hilger, D Díaz-Carballo, S Bauer, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 16, 2004
Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantationR A Hilger, J Baumgart, M E Scheulen, et al.
Applied and Environmental Microbiology|December 31, 2008
Molecular diversity of a North Carolina wastewater treatment plant as revealed by pyrosequencingNina Sanapareddy, Timothy J Hamp, Luis C Gonzalez, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
The growing number of hemophilia registries: Quantity vs. qualityC Keipert, J Hesse, B Haschberger, et al.
Seminars in Oncology|February 19, 2005
Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studiesDavid M Vail, Michael A Amantea, Gail T Colbern, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Comment on: Mannucci, P. M. Evolution of the European guidelines for the clinical development of factor VIII productsA Hilger, C Arras-Reiter, B Keller-Stanislawski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2014
Research in haemophilia B--approaching the request for high evidence levels in a rare diseaseK Berger, D Schopohl, A Hilger, et al.
Oncotarget|May 2, 2013
Cell death sensitization of leukemia cells by opioid receptor activationClaudia Friesen, Mareike Roscher, Inis Hormann, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumorsR A Hilger, A Harstrick, W Eberhardt, et al.
Pageof 15